Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 – a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34:1013–27.
McCallum CJ, Raja DC, Pathak RK. Atrial fibrillation: an update on management. Aust Prescr. 2019;42(6):186–91. https://doi.org/10.18773/austprescr.2019.067.
Article PubMed PubMed Central Google Scholar
Dunn AS, Turpie AGG. Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review. Arch Intern Med. 2003;163(8):901–8. https://doi.org/10.1001/archinte.163.8.901.
Birnie DH, Healey JS, Wells GA, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368(22):2084–93.
Article CAS PubMed Google Scholar
Carbone A, Bottino R, D’Andrea A, Russo V. Direct Oral Anticoagulants for Stroke Prevention in Special Populations: Beyond the Clinical Trials. Biomedicines. 2023;11(1):131. https://doi.org/10.3390/biomedicines11010131.
Article CAS PubMed PubMed Central Google Scholar
Birnie DH, Healey JS, Wells GA, et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart J. 2018;39(44):3973–9.
Article CAS PubMed Google Scholar
Creta A, Finlay M, Hunter RJ, et al. Non-vitamin K oral anticoagulants at the time of cardiac rhythm device surgery: a systematic review and metaanalysis. Thromb Res. 2020;188:90–6.
Article CAS PubMed Google Scholar
Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, Fargo RA, Levy JH, Samama CM, Shah SH, Sherwood MW, Tafur AJ, Tang LV, Moores LK. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2022;162(5):e207–43. https://doi.org/10.1016/j.chest.2022.07.025.
Article CAS PubMed Google Scholar
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylén I, Tolosana JM, ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427–520. https://doi.org/10.1093/eurheartj/ehab364.
Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR, Peer Review Committee Members. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1–156. https://doi.org/10.1161/CIR.0000000000001193.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.
Article PubMed PubMed Central Google Scholar
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA. 2000;283(15):2008–12. https://doi.org/10.1001/jama.283.15.2008.
Article CAS PubMed Google Scholar
Sterne JAC, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.4. Cochrane. 2023. Available from www.training.cochrane.org/handbook.
Sterne JAC, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JPT. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919.
Article PubMed PubMed Central Google Scholar
Ricciardi D, Creta A, Colaiori I, Scordino D, Ragni L, Picarelli F, et al. Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trial. Pacing Clin Electrophysiol. 2018;41(11):1476–80.
Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–4. https://doi.org/10.1111/j.1538-7836.2005.01204.x.
Article CAS PubMed Google Scholar
Black-Maier E, Kim S, Steinberg BA, Fonarow GC, Freeman JV, Kowey PR, Ansell J, Gersh BJ, Mahaffey KW, Naccarelli G, Hylek EM, Go AS, Peterson ED, Piccini JP, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. Clin Cardiol. 2017;40(9):746–51. https://doi.org/10.1002/clc.22726.
Article PubMed PubMed Central Google Scholar
Creta A, Ventrella N, Earley MJ, Finlay M, Sporton S, Maclean E, Kanthasamy V, Lemos Silva Di Nubila BC, Ricciardi D, Calabrese V, Picarelli F, Hunter RJ, Lambiase PD, Schilling RJ, Grigioni F, Monkhouse C, Muthumala A, Moore P, Providencia R, Chow A. DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study. JACC Clin Electrophysiol. 2024;10(1):121–32. https://doi.org/10.1016/j.jacep.2023.08.037.
Rowley CP, Bernard ML, Brabham WW, Netzler PC, Sidney DS, Cuoco F, Sturdivant JL, Leman RB, Wharton JM, Gold MR. Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol. 2013;111(8):1165–8. https://doi.org/10.1016/j.amjcard.2012.12.046.
Article CAS PubMed Google Scholar
Sheikh MA, Kong X, Haymart B, Kaatz S, Krol G, Kozlowski J, Dahu M, Ali M, Almany S, Alexandris-Souphis T, Kline-Rogers E, Froehlich JB, Barnes GD. Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures. Thromb Res. 2021;203:27–32. https://doi.org/10.1016/j.thromres.2021.04.006.
Article CAS PubMed PubMed Central Google Scholar
Sheldon SH, Cunnane R, Lavu M, Parikh V, Atkins D, Reddy YM, Berenbom LD, Emert MP, Pimentel R, Dendi R, Lakkireddy DR. Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies. Pacing Clin Electrophysiol. 2018;41(7):799–806. https://doi.org/10.1111/pace.13349.
Unverdorben M, von Heymann C, Santamaria A, Saxena M, Vanassche T, Wilkins R, Jin J, Chen C, Colonna P. Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT program. Pacing Clin Electrophysiol. 2022;45(1):83–91. https://doi.org/10.1111/pace.14381.
Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019;179(11):1469–78. https://doi.org/10.1001/jamainternmed.2019.2431.
Article PubMed PubMed Central Google Scholar
Essebag V, Proietti R, Birnie DH, Wang J, Douketis J, Coutu B, Parkash R, Lip GYH, Hohnloser SH, Moriarty A, Oldgren J, Connolly SJ, Ezekowitz M, Healey JS. Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. Europace. 2017;19(10):1630–6. https://doi.org/10.1093/europace/euw409.
Tsai CT, Liao JN, Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Chung FP, Tuan TC, Chen SA. Uninterrupted non-vitamin K antagonist oral anticoagulants during implantation of cardiac implantable electronic devices in patients with atrial fibrillation. J Chin Med Assoc. 2019;82(4):256–9. https://doi.org/10.1097/JCMA.0000000000000050.
Milling TJ, Pollack CV. A review of guidelines on anticoagulation reversal across different clinical scenarios - Is there a general consensus? Am J Emerg Med. 2020;38(9):1890–903. https://doi.org/10.1016/j.ajem.2020.05.086.
留言 (0)